ChinaFocus@San Francisco | JP Morgan Conferences 2020 | Premier Biotech and Healthcare Events

Global Life Science Summit

January 9-12, 2023



Shanghai, Suzhou, Nanjing, Shenzhen

Registration

Jan. 9, 2023
Shanghai

Jan. 10, 2023
Suzhou

Jan. 11, 2023
Nanjing

Jan. 12, 2023
Shenzhen

ABOUT CHINA FOCUS

China has embraced a vigorously growing healthcare market in the past decade. Ever since joining ICH in 2017, China has seen increased clinical trials and accelerated new drug and device approval. For biotech and medtech companies outside of China, you need to find the right partners and the right resources to bring your products to China, in order to adapt to difference in culture, regulation, reimbursement, etc. In the meantime, Chinese biotechs are actively seeking global market entry opportunities and oversea partners.

China Focus is a partnering forum designed to provide a meaningful platform to inform, inspire, and foster cross-border partnership in life science and healthcare.

Who should attend

Investors (VC, PE, investment bank, etc.)
Life science innovators and entrepreneurs
Biotech & big pharma
Medtech (device and diagnostics) manufacturers and distributors
Service providers (law firm, financial advisory, regulatory consulting, CRO, CDMO, etc.)
Healthcare providers

MAIN TOPICS

Cross-border investment: money from the East and the West
Innovations going to China: regulation, market access, manufacturing and distribution
Chinese innovations going west: partnership for capital and market access in the U.S.

WHAT YOU CAN GET

Learn about Chinese life science and healthcare industry
Hear about the latest Chinese regulatory reforms and implications
Meet with the decision makers in the industry
Initiate business conversations that otherwise difficult to start

REGISTRATION

shanghai Agenda

9:00-9:20●

Opening Speech

Ruicong Tan, Secretary of the Party Committee of the National Innovation Center par Excellence
Xinxin Li, Vice President of Strategic Partnerships, MyBioGate

9:20-9:40●

Keynote Speeches: Immunotherapy targeting NK cells

Speaker: Zhigang Tian, Founder of TG ImmunoPharma (TGI) and NK CellTech, Academician of Chinese Academy of Engineering, Academician of Academia Europaea

9:40-10:10 ●

Keynote Speech: Interpretation of Global Biomedical Cross-border Trends in 2022-2023

Speaker: Dr. Qicong Hu, Partner and Managing Director of Boston Consulting Group

10:10-10:50 ●

Panel Discussion 1: Opportunities for Multinational Pharmaceutical Companies in the Chinese Market in 2023

Moderator: Xin Wang, Asia Pacific Regional Director of Servier Pharmaceutical Global Business Development
Guests:
He Sun, Head of Business Development and Pipeline Planning Department of Eisai China
Jun Song, Head of Chinese Business Development of Novartis Global Biomedical Research Center
Li Yu, Director of Chinese Strategy and Business Development of Huirui Investment

10:50-11:00 ●

Break

11:00-11:20 ●

Keynote Speech: To Be Determined

Speaker: Katherine Andersen, Head of Client Relations of Life Sciences and Healthcare of Silicon Valley Bank

11:20-12:00●

Panel Discussion 2: The Global Development Path of Pharmaceutical Companies under the Strategic Layout of "Innovation & Internationalization"

Moderator: Jingye Wang, Partner and Head of Business in China of L.E.K. Consulting
Guests:
Mei Li, Deputy General Manager of Strategic Development Center of Fosun Pharma
Han Dai, Chief Innovation Officer of VIVA Biotech and Head of Viva Biotech Innovation Center
Di Yang, Director, Vice President and Secretary of the Board of Directors of Hybio Pharmaceutical
Fei Jiang, Chief Investment Officer of China Medical System

12:00-14:00●

Lunch Break

14:00-14:20●

Keynote Speech: Innovating through Change: The New Outlook of China Res Double-Crane in 2023 (online)

Speaker: Zhanjun Cui, Deputy General Manager of Market Development Department and Team Leader of Product Introduction of China Res Double-Crane

14:20-15:20●

Panel Discussion 3: New Opportunities for Biomedical Development Collaboration in Various Countries from the Perspective of Chinese Foreign-related Institutions and Embassies and Consulates in China

Moderator: Dr. Benjin Luo, Chief Expert of the National Innovation Center par Excellence
Guests:
Qingyu Zhu, Head of the Greater China Medical and Health Industry Group of the Australian Embassy and Consulates in China
Xiong Zhang, Secretary-General of the PHARNEX, sub-branch of China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), former official of the Economic and Commercial Office of the Chinese Embassy in Nigeria
Yubo Guo, Officer of Health and Life Science Innovation, Danish Science and Technology Entrepreneurship Center, Consulate General of Denmark in Shanghai
Danyi Quan, Chairman & Director of Institute of Advanced Drug Delivery Technology of Jiangsu Jirate Pharmaceutical Preparation Technology Research Institute

15:20-15:30●

Break

15:30-16:30●

Panel Discussion 4: Discussion on China's Biomedical Investment Trends in 2023

Moderator: Liang Zhang, Partner of IN CAPITAL
Jianlin Yu, Partner of GTJA Investment Group
Jing Yu, Partner of Med-fine Capital
Nannan Chang, Executive Director of Hillhouse
Yichao Fan, Deputy Investment Director of AstraZeneca CICC Medical Industry Fund
Jing Xu, Vice President of Investment of LYFE Capital

16:30-17:30●

Panel Discussion 5: Survival and Development of Chinese Biotech Companies in the Next 5 Years

Moderator: Jin Cao, Entrepreneurship Mentor of National Major Talent Project, Entrepreneurship Mentor of Yeehong Business School
Guests:
Ying Ke, Director, Deputy Director of R&D Management Center, General Manager of Global R&D Cooperation Department of Shanghai Pharmaceuticals
Yanci Sheng, General Manager of Global Strategy and Project Management of Shanghai Henlius Biotech
Qiang Yu, Founder & CEO of CGeneTech
Yuanhua Ding, CEO of E-nitiate Biopharmaceuticals